OEM News, People

Owlet Reveals CEO Transition, Reaffirms Q1 Guidance

Jonathan Harris resigned as president and CEO, co-founder and prior CEO Kurt Workman will take the position.

Author Image

By: Sam Brusco

Associate Editor

Owlet, a company specializing in smart infant monitoring, announced that Jonathan Harris has resigned as president and CEO, effective immediately.

Kurt Workman, current executive chair of the board, co-founder, and former CEO, will rejoin as president and CEO to lead the company. Workman will stop serving as the board’s executive chairman, but will stay a director on the board.

“I’m incredibly excited to have Kurt back in the CEO role,” said Lior Susan, Owlet’s chairman of the board. “His strategic vision for the future of Owlet and his demonstrated ability to effectively execute on that vision make him uniquely qualified for the CEO role as we enter this next chapter of the business. The Board and I welcome his energy and commitment to leading the Owlet team as we solidify our leadership position as partners to the next generation of families, globally.”

Owlet said it expects to be at the high end of its Q1 2026 revenue guidance range. The company will report Q1 2026 financial results and business outlook in early May.

The company also reaffirmed its long-term strategies of growing adoption, expanding LTV, and leveraging its growing data set to create the pediatric health platform parents need.

“My return as CEO is a commitment to the mission I started in a garage 12 years ago,” said Kurt Workman. “Owlet is the category leader in pediatric health monitoring with an unparalleled data set, yet there is still an immense opportunity to increase our market penetration, accelerate adoption and improve the health and wellness of infants worldwide. I am stepping back in to deliver on this vision. My goal is to make Owlet the standard for at-home pediatric health, and I’m ready to get back to work with this incredible team, our amazing partners and the parents around the world that put their faith and trust in the Owlet brand.”

The company recently formed a new strategic partnership with PromptCare to expand access to its U.S. Food and Drug Administration (FDA)-cleared prescription pulse oximeter, BabySat, through established pediatric care pathways.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters